ALB and pancreatic neoplasm: In addition, Yu et al. modified the surface of liposome-encapsulated albumin nanoparticles containing paclitaxel with both an enzyme-responsive peptide (fibroblast-activated protein-a responsive cleavable amphiphilic peptide) and a photothermal agent (IR-780) to increase the therapeutic efficacy of the system against pancreatic tumors [52].